AzTrials
AzTrials

Medial Epicondyle ApophysitisNCT07723677

Powerball for Medial Epicondyle Apophysitis

A study testing BowerBall Group in people with Medial Epicondyle Apophysitis, run by Nehad Ahmed Youness Abo-zaid at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Traction apophysitis of the medial epicondyle (MEC) is a common elbow injury in adolescent baseball players. The underlying pathology of the lesions associated with apophysitis seems to be due to repetitive traction stress via the medial ulnar collateral ligament (MUCL) to the skeletally immature MEC, as seen in young… Read more about this study

Who is it for?
Ages 12 to 18 years
Conditions the study is for
Medial Epicondyle Apophysitis
What is being tested?
BowerBall Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
2 Aug 2026to 20 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Their age will be ranging from 12 to 18 years.
  • Cases diagnosed with medial epicondyle apophysitis.
  • Cases participated in this study will from both sexes.
  • Cases receiving standard treatment protocol.
  • Cases with a disease duration of more than four months

Who cannot join

  • Cases with resent fractures in affected upper limb.
  • Cases diagnosis of any neurological disease or musculoskeletal disease affecting upper extremity functional ability.
  • Uncooperative cases.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nehad A Abo-zaid,, Assistant Professor contact

01008980727

dr.nehadahmed@svu.edu.eg

Ola A A Kamal, Lecturer, Lecturer contact

01118458838

Egypt1 site
  • Nehad A Abo-zaid

    Asyut

    Nehad A Abo-zaid,, Assistant Professor, 01008980727, dr.nehadahmed@svu.edu.eg

Other trials in Egypt

About this study

Official title: The Efficacy of Powerball Training on Medial Epicondyle Apophysitis in Adolescent Athletes

Traction apophysitis of the medial epicondyle (MEC) is a common elbow injury in adolescent baseball players. The underlying pathology of the lesions associated with apophysitis seems to be due to repetitive traction stress via the medial ulnar collateral ligament (MUCL) to the skeletally immature MEC, as seen in young baseball players. Various types of morphological changes are observed at the MEC in baseball players, and fragmentation and hypertrophy have been commonly reported

Read the detailed description

Phases of rehabilitation for Medial Epicondyle Apophysitis Phase I treatment involves resting and protecting the elbow to permit healing, to prevent further injury, and to control pain and swelling. Phase II treatment begins once pain and swelling have subsided to the point where the athlete can comfortably bear weight and walk from place to place. According to recent studies, vibrating devices like the PowerBall gadget have a greater effect on people with tennis elbow injuries than dumbbell exercise does on muscular strength, discomfort, range of motion, and health quality. Exercises using the "PowerBall device" are thought to be effective resistance training during the chronic period because the muscles of the wrist, elbow, and shoulder, apply both internal and external pressure. Muscle strength may have grown over this period because of neurovascularization, the creation of new blood vessels during the eccentric phase of training that enhances blood flow and speeds up tissue repair.

Being tested
the control group, BowerBall Group
Keywords
Medial Epicondyle Apophysitis, PowerBall

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • the control groupOther

    Also called Group (A)

    All adolescents will receive 60 min. of the selected physical therapy program including strengthening the muscles of upper limb, stretching for elbow flexors and forearms pronators

  • BowerBall GroupOther

    all adolescents will receive selected physical therapy program for 30 min. containing strengthening the muscles of upper limb, stretching for elbow flexors and forearms pronators plus 30 of BowerBalltraining

Study groups in NCT07723677
Study groupRoleWhat they receive
The Control Group Group (A)ExperimentalNot described
Receives: Other: the control group
The Study Group Group (B)ExperimentalThe Study Group Group (B)
Receives: Other: BowerBall Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale

    pain assessment tool, the scale ranged from 0-10 (at which 0 indicate no pain and 10 indicate sever pain)

    Measured: at day 0

  2. Visual Analogue Scale

    pain assessment tool, the scale ranged from 0-10 (at which 0 indicate no pain and 10 indicate sever pain)

    Measured: at day 90

Secondary outcomes (4)
  1. Range of Motion

    Elbow Flexion angle degree

    Measured: at day 0

  2. Range of Motion

    Elbow Flexion angle degree

    Measured: at day 90

  3. Range of Motion

    Elbow Extension angle degree

    Measured: at day 0

  4. Range of Motion

    Elbow Extension angle degree

    Measured: at day 90

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2026
  2. Study start2 Aug 2026 (estimated)
  3. Primary completion8 Oct 2026 (estimated)
  4. Study completion20 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
G 1 (control) received traditional physical therapy program for 60 min. G 2 (study) received traditional physical therapy program for 30 min. and PowerBall for 30 min. all groups treated for 3 successive months.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07723677
Sponsor's protocol ID
P.T.REC/012/006567
Status last verified
Jul 2026
First submitted
19 Jul 2026
Last updated
23 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • T. Tsuruta, H. Mine The primary treatment for the inferior fragmentation of humeral medial epicondyle in young baseball players J Jpn Elbow Soc, 20 (2013), pp. 92-95

  • Takagishi K, Matsuura T, Masatomi T, Chosa E, Tajika T, Watanabe M, Iwama T, Otani T, Inagaki K, Ikegami H, Aoki M, Kato K, Okuwaki T, Sairyo K, Kameyama Y, Maeda A, Beppu M. Shoulder and elbow pain in elementary school baseball players: The results from a nation-wide survey in Japan. J Orthop Sci. 2017 Jul;22(4):682-686. doi: 10.1016/j.jos.2017.03.016. Epub 2017 May 3.

    PubMed 28478963
  • Osbahr DC, Chalmers PN, Frank JS, Williams RJ 3rd, Widmann RF, Green DW. Acute, avulsion fractures of the medial epicondyle while throwing in youth baseball players: a variant of Little League elbow. J Shoulder Elbow Surg. 2010 Oct;19(7):951-7. doi: 10.1016/j.jse.2010.04.038. Epub 2010 Aug 5.

    PubMed 20688542
  • Harada M, Takahara M, Sasaki J, Mura N, Ito T, Ogino T. Using sonography for the early detection of elbow injuries among young baseball players. AJR Am J Roentgenol. 2006 Dec;187(6):1436-41. doi: 10.2214/AJR.05.1086.

    PubMed 17114533
  • Hodge C, Schroeder JD. Medial Epicondyle Apophysitis (Little League Elbow). 2023 Mar 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK570592/

    PubMed 34033354
  • Otoshi K, Kikuchi S, Kato K, Kaneko Y, Mashiko R, Sato R, Igari T, Kaga T, Konno S. The influence of chronic medial epicondylar apophysitis on medial ulnar collateral ligament insufficiency-: a retrospective cohort study. JSES Int. 2022 Feb 1;6(3):539-544. doi: 10.1016/j.jseint.2021.12.014. eCollection 2022 May.

    PubMed 35572434

Questions about this trial

What is this clinical trial studying?

A study testing BowerBall Group in people with Medial Epicondyle Apophysitis, run by Nehad Ahmed Youness Abo-zaid at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nehad A Abo-zaid,, Assistant Professor (01008980727, dr.nehadahmed@svu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale (time frame: at day 0). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07723677, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in